To avoid precipitating withdrawal, induction with SUBOXONE sublingual film should be undertaken when objective and clear signs of withdrawal are evident and SUBOXONE sublingual film should be administered in divided doses when used as initial treatment. For patients dependent on short‐acting opioid products who are in opioid withdrawal; on Day 1, administer up to 8 mg/2 mg SUBOXONE sublingual film (in divided doses). On Day 2, administer up to 16 mg/4 mg of SUBOXONE sublingual film as a single dose. For patients dependent on methadone or long‐acting opioid products, induction onto sublingual buprenorphine monotherapy is recommended on Days 1 and 2 of treatment. For maintenance treatment, the target dosage of SUBOXONE strips sublingual film is usually 16 mg/4 mg as a single daily dose Sublingual Administration: Place one film under the tongue, close to the base on the left or right side, and allow to completely dissolve. Buccal Administration: Place one film on the inside of the left or right cheek and allow to completely dissolve. SUBOXONE sublingual film must be administered whole. Do not cut, chew, or swallow SUBOXONE sublingual film.
$180 / 60 Pills
$250 / 100 Pills
$405 / 150 Pills
$480 / 200 Pills
08mg/2mg. Manufactured by Reckitt Benckiser.
Suboxone is a prescription medication that combines buprenorphine and naloxone. It’s used to treat opioid addiction. (Heroin and narcotic painkillers are common opioid drugs.) Buprenorphine belongs to a class of drugs called opioidpartial agonists, which help relieve symptoms of opiate withdrawal Suboxone pills contains a combination of buprenorphine and naloxone. Buprenorphine is an opioid medication, sometimes called a narcotic. Naloxone blocks the effects of opioid medication, including pain relief or feelings of well-being that can lead to opioid abuse. Suboxone is used to treat narcotic (opiate) addiction.